Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes.

Mullins DW, Engelhard VH.

J Immunol. 2006 Apr 15;176(8):4535-42.

PMID:
16585543
[PubMed - indexed for MEDLINE]
Free Article
2.

Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.

Preynat-Seauve O, Contassot E, Schuler P, French LE, Huard B.

Melanoma Res. 2007 Jun;17(3):169-76.

PMID:
17505262
[PubMed - indexed for MEDLINE]
3.

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

Stoitzner P, Green LK, Jung JY, Price KM, Atarea H, Kivell B, Ronchese F.

Cancer Immunol Immunother. 2008 Nov;57(11):1665-73. doi: 10.1007/s00262-008-0487-4. Epub 2008 Mar 1.

PMID:
18311487
[PubMed - indexed for MEDLINE]
4.

Comparison of CTL reactivity in the spleen and draining lymph nodes after immunization with peptides pulsed on dendritic cells or mixed with Freund's incomplete adjuvant.

Wang MJ, Nissen MH, Buus S, Röpke C, Claësson MH.

Immunol Lett. 2003 Nov 15;90(1):13-8.

PMID:
14611902
[PubMed - indexed for MEDLINE]
5.

Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.

Kamath AT, Valenti MP, Rochat AF, Agger EM, Lingnau K, von Gabain A, Andersen P, Lambert PH, Siegrist CA.

Eur J Immunol. 2008 May;38(5):1247-56. doi: 10.1002/eji.200737889.

PMID:
18412160
[PubMed - indexed for MEDLINE]
6.

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.

Wells JW, Cowled CJ, Darling D, Guinn BA, Farzaneh F, Noble A, Galea-Lauri J.

Cancer Immunol Immunother. 2007 Dec;56(12):1861-73. Epub 2007 May 9.

PMID:
17487489
[PubMed - indexed for MEDLINE]
7.

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.

Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM, Strijk S, Eijckeler F, Bonenkamp JJ, Jacobs JF, Blokx W, Vankrieken JH, Joosten I, Boerman OC, Oyen WJ, Adema G, Punt CJ, Figdor CG, de Vries IJ.

Clin Cancer Res. 2009 Apr 1;15(7):2531-40. doi: 10.1158/1078-0432.CCR-08-2729. Epub 2009 Mar 24.

PMID:
19318472
[PubMed - indexed for MEDLINE]
Free Article
8.

Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.

Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.

Clin Immunol. 2009 Nov;133(2):184-97. doi: 10.1016/j.clim.2009.07.008. Epub 2009 Aug 7.

PMID:
19664962
[PubMed - indexed for MEDLINE]
9.

Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors.

Huck SP, Tang SC, Andrew KA, Yang J, Harper JL, Ronchese F.

Cancer Immunol Immunother. 2008 Jan;57(1):63-71. Epub 2007 Jul 3.

PMID:
17609951
[PubMed - indexed for MEDLINE]
10.

Dendritic cells incubated with irradiated tumor cells effectively stimulate T lymphocyte activation and induce enhanced expression of CD69, CD25 as well as production of IFNgamma and IL4.

Stegel V, Kopitar A, Jezersek Novaković B, Ihan A, Novaković S.

Int Immunopharmacol. 2006 Jan;6(1):79-89. Epub 2005 Aug 25.

PMID:
16332516
[PubMed - indexed for MEDLINE]
11.

CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.

del Rio ML, Rodriguez-Barbosa JI, Kremmer E, Förster R.

J Immunol. 2007 Jun 1;178(11):6861-6.

PMID:
17513734
[PubMed - indexed for MEDLINE]
Free Article
12.

[Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].

Tan XH, Liu C, Wan YH.

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):658-61. Chinese.

PMID:
17274369
[PubMed - indexed for MEDLINE]
13.

Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.

Preynat-Seauve O, Schuler P, Contassot E, Beermann F, Huard B, French LE.

J Immunol. 2006 Jan 1;176(1):61-7.

PMID:
16365396
[PubMed - indexed for MEDLINE]
Free Article
14.

Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation.

Constabel H, Stankov MV, Hartwig C, Tschernig T, Behrens GM.

J Immunol. 2009 Sep 1;183(5):3443-53. doi: 10.4049/jimmunol.0804223. Epub 2009 Aug 10.

PMID:
19667097
[PubMed - indexed for MEDLINE]
Free Article
15.

NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain.

Prins RM, Vo DD, Khan-Farooqi H, Yang MY, Soto H, Economou JS, Liau LM, Ribas A.

J Immunol. 2006 Dec 15;177(12):8448-55.

PMID:
17142742
[PubMed - indexed for MEDLINE]
Free Article
16.

Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.

Chung Y, Chang JH, Kim BS, Lee JM, Kim HY, Kang CY.

Eur J Immunol. 2007 Jun;37(6):1453-62.

PMID:
17474148
[PubMed - indexed for MEDLINE]
17.

Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen.

Henri S, Siret C, Machy P, Kissenpfennig A, Malissen B, Leserman L.

Eur J Immunol. 2007 May;37(5):1184-93.

PMID:
17407099
[PubMed - indexed for MEDLINE]
18.

Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo.

Wurzenberger C, Koelzer VH, Schreiber S, Anz D, Vollmar AM, Schnurr M, Endres S, Bourquin C.

Cancer Immunol Immunother. 2009 Jun;58(6):901-13. doi: 10.1007/s00262-008-0606-2. Epub 2008 Oct 25.

PMID:
18953536
[PubMed - indexed for MEDLINE]
19.

Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.

Vuylsteke RJ, Molenkamp BG, van Leeuwen PA, Meijer S, Wijnands PG, Haanen JB, Scheper RJ, de Gruijl TD.

Clin Cancer Res. 2006 May 1;12(9):2826-33.

PMID:
16675577
[PubMed - indexed for MEDLINE]
Free Article
20.

Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.

Iezzi G, Fröhlich A, Ernst B, Ampenberger F, Saeland S, Glaichenhaus N, Kopf M.

J Immunol. 2006 Jul 15;177(2):1250-6.

PMID:
16818784
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk